DMSO And Conditions It Can Treat

As we have discussed before, Stanley Jacob MD, a researcher and authority on DMSO has stated that since the early 1960s (http://www.dmso.org) has stated that DMSO's pharmacological actions and efficaciousness have been documented in hundreds of laboratory studies. DMSO holds promise in treating a number of conditions including the following:

• Alzheimer's disease. DMSO has been shown to dissolve amyloids, the proteins that occur in the hallmark brain lesions of patients with Alzheimer's and almost invariably lead to the functional loss and eventual death of brain cells.

• Arthritis. With its ability to penetrate tissues, DMSO shows value in reducing pain and inflammation in osteoarthritis, rheumatoid arthritis, and possibly gout. o Atherosclerosis. In laboratory animals, DMSO has demonstrated its ability to retard the development of atherosclerosis induced by dietary cholesterol, as well as suppress the accumulation of cholesterol in tissues despite severe hypercholesterolemia (elevated blood levels of cholesterol).

• Down's syndrome. Researchers have noted that when children born with Down's syndrome were treated with DMSO, mental and neurological functions improved in a number of areas. o Drug extravasation injury. When chemotherapy drugs exude into surrounding tissues (extravasate), the effects are highly damaging. DMSO application significantly improved anthracycline-associated extravasation tissue injury in a study conducted by Stephen B. Strum, MD, a member of the Life Extension Foundation's Scientific Advisory Board.

• Fibrtmyalgia. According to Dr. Jacob, 70% of fibromyalgia patients he treated with DMSO for several years experienced benefits with no side effects. He believes these effects were due to pharmacological actions of DM50 such as free-radical scavenging, analgesia, anti-inflammation, softening of scartissue, reduction of muscle spasms, and stimulation of healing.

• Herpes. DMSO has been used to enhance penetration of alpha-interferon ointment in the treatment of herpes. o Interstitial cystitis. Instilling DMSO in the urinary bladder is an FDA-approved palliative treatment for this chronic inflammatory condition. o Malignancy. Researchers concluded DMSO exerts a significant survival advantage in gastric cancer.

• Plastic surgery adjunct. DMSO has been shown to aid healing and reduce pain and swelling.

• Prostatitis. Significant symptomatic relief occurred when DMSO was injected by catheter into the prostatic urethra.

• Reflex sympathetic dystrophy. DMSO helps relieve the pain of this condition, an autonomic nervous system disorder characterized primarily by overwhelming pain in the extremities. Dr. Jacob notes that in Holland, a physician is breaking the law if he does not prescribe topical DMSO for reflex sympathetic dystrophy.

• Scleroderma. In basic work done at the Cleveland Clinic, topical DMSO was found to have an anti-inflammatory effect while increasing blood supply to the skin.

• Spinal cord injury. Data shows that if DMSO is given intravenously within the first 45-60 minutes after injury, the number of laboratory animals that recover was much higher than in those not receiving DMSO. Dr. Jacob says this is an area he would like to pursue, noting, "If we have 10,000 severe spinal cord injuries per year in the US-quadriplegic and paraplegic-there could be fewer patients who will need long-term care.

• Stroke. DMSO combined with a sugar that fuels energy production was well tolerated in elderly stroke patients, and could be of benefit in reducing neurological disability after stroke.

• Ulcerative colitis. In controlled human studies, orally administered DMSO produced some improvement in the condition.

Why does our FDA continue to block this as a natural healing compound? We all know the answer to that and it's appaling!